Nigel Howard

590 total citations
11 papers, 469 citations indexed

About

Nigel Howard is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Nigel Howard has authored 11 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Organic Chemistry. Recurrent topics in Nigel Howard's work include Chemical Synthesis and Analysis (3 papers), Peptidase Inhibition and Analysis (2 papers) and Bacterial Genetics and Biotechnology (2 papers). Nigel Howard is often cited by papers focused on Chemical Synthesis and Analysis (3 papers), Peptidase Inhibition and Analysis (2 papers) and Bacterial Genetics and Biotechnology (2 papers). Nigel Howard collaborates with scholars based in United Kingdom, United States and Brazil. Nigel Howard's co-authors include Chris Abell, Timothy D. H. Bugg, Olivier Kerbarh, Alessio Ciulli, Courtney Davis, N.R. Kitteringham, Munir Pirmohamed, Christopher W. Murray, Wendy Blakemore and Steven Howard and has published in prestigious journals such as Journal of Molecular Biology, Chemical Communications and Biochemical Journal.

In The Last Decade

Nigel Howard

11 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nigel Howard United Kingdom 9 315 118 103 84 72 11 469
Zhenting Gao China 7 360 1.1× 164 1.4× 68 0.7× 22 0.3× 47 0.7× 11 534
María Gálvez-Llompart Spain 14 224 0.7× 283 2.4× 197 1.9× 39 0.5× 52 0.7× 47 517
Hung-Jin Huang Taiwan 10 350 1.1× 222 1.9× 71 0.7× 53 0.6× 71 1.0× 11 557
M.P. Hudock United States 8 394 1.3× 60 0.5× 105 1.0× 57 0.7× 145 2.0× 10 574
Sarah Tomas‐Hernández Spain 7 234 0.7× 143 1.2× 56 0.5× 61 0.7× 64 0.9× 10 418
Joshua Pottel Canada 12 224 0.7× 115 1.0× 118 1.1× 36 0.4× 23 0.3× 19 415
Sophie Hoenke Germany 14 338 1.1× 37 0.3× 113 1.1× 35 0.4× 61 0.8× 51 488
Franca‐Maria Klingler Germany 13 207 0.7× 123 1.0× 121 1.2× 31 0.4× 144 2.0× 18 545
Ugo Perricone Italy 15 316 1.0× 188 1.6× 134 1.3× 38 0.5× 40 0.6× 40 545
Santosh N. Mokale India 15 195 0.6× 93 0.8× 340 3.3× 19 0.2× 68 0.9× 52 622

Countries citing papers authored by Nigel Howard

Since Specialization
Citations

This map shows the geographic impact of Nigel Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Howard more than expected).

Fields of papers citing papers by Nigel Howard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Howard. The network helps show where Nigel Howard may publish in the future.

Co-authorship network of co-authors of Nigel Howard

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel Howard. A scholar is included among the top collaborators of Nigel Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel Howard. Nigel Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Howard, Nigel, M.V.B. Dias, Fabienne Peyrot, et al.. (2014). Design and Structural Analysis of Aromatic Inhibitors of Type II Dehydroquinase from Mycobacterium tuberculosis. ChemMedChem. 10(1). 116–133. 7 indexed citations
2.
Ballester, Pedro J., Nigel Howard, Richard Marchese Robinson, et al.. (2012). Hierarchical virtual screening for the discovery of new molecular scaffolds in antibacterial hit identification. Journal of The Royal Society Interface. 9(77). 3196–3207. 60 indexed citations
3.
Schmidt, Marco F., Oliver Korb, Nigel Howard, et al.. (2012). Discovery of Schaeffer’s Acid Analogues as Lead Structures of Mycobacterium tuberculosis Type II Dehydroquinase Using a Rational Drug Design Approach. ChemMedChem. 8(1). 54–58. 11 indexed citations
4.
Dias, M.V.B., Richard J. Payne, S.K. Palaninathan, et al.. (2011). Structural investigation of inhibitor designs targeting 3-dehydroquinate dehydratase from the shikimate pathway of Mycobacterium tuberculosis. Biochemical Journal. 436(3). 729–739. 35 indexed citations
5.
6.
Howard, Nigel, Chris Abell, Wendy Blakemore, et al.. (2006). Application of Fragment Screening and Fragment Linking to the Discovery of Novel Thrombin Inhibitors. Journal of Medicinal Chemistry. 49(4). 1346–1355. 102 indexed citations
7.
Kerbarh, Olivier, Alessio Ciulli, Nigel Howard, & Chris Abell. (2005). Salicylate Biosynthesis: Overexpression, Purification, and Characterization of Irp9, a Bifunctional Salicylate Synthase fromYersinia enterocolitica. Journal of Bacteriology. 187(15). 5061–5066. 66 indexed citations
8.
Howard, Nigel & Timothy D. H. Bugg. (2003). Synthesis and activity of 5′-Uridinyl dipeptide analogues mimicking the amino terminal peptide chain of nucleoside antibiotic mureidomycin A. Bioorganic & Medicinal Chemistry. 11(14). 3083–3099. 48 indexed citations
9.
10.
Howard, Nigel, David T. Hickman, Steven A. Adah, et al.. (2000). Replacement of the phosphodiester linkage in DNA with sulfamide and 3′-N-sulfamate groups. Chemical Communications. 765–766. 8 indexed citations
11.
Kitteringham, N.R., et al.. (1996). Interindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamazepine 10, 11-epoxide and naphthalene.. Journal of Pharmacology and Experimental Therapeutics. 278(3). 1018–1027. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenting Gao Breakdown of academic impact, for papers by María Gálvez-Llompart Breakdown of academic impact, for papers by Hung-Jin Huang Breakdown of academic impact, for papers by M.P. Hudock Breakdown of academic impact, for papers by Sarah Tomas‐Hernández Breakdown of academic impact, for papers by Joshua Pottel Breakdown of academic impact, for papers by Sophie Hoenke Breakdown of academic impact, for papers by Franca‐Maria Klingler Breakdown of academic impact, for papers by Ugo Perricone Breakdown of academic impact, for papers by Santosh N. Mokale
Rankless by CCL
2026